Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

fesoterodine

fesoterodine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Toviaz TABLET, EXTENDED RELEASE, ORAL 4 mg, 8 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

fesoterodine (Toviaz)

  • 4 mg extended release tablet Daily
  • 8 mg extended release tablet Daily

oxybutynin (Ditropan XL)

  • 10 mg/24 hr extended release tablet Daily
  • 15 mg/24 hr extended release tablet Daily

Reviewed: January 27, 2009

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved